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 2013 Elsevier Ltd. All rights reserved.Chelidonic acid, a c-pyrone compound with the structure
shown in Figure 1, is a naturally occurring compound that is widely
distributed among many plants.1 It is contained in the rhizomes of
Chelidonium majus L. at quite high concentrations, and has multiple
pharmacological effects including mild analgesic, antimicrobial,
oncostatic, and central nervous system sedation.2 In addition,
chelidonic acid and chelidamic acid were the most potent inhibi-
tors of glutamate decarboxylase from rat brain,3 and may attenuate
allergic reactions by inhibition of caspase-1 activity.4
Unlike well-studied diethyl chelidonate,5 diethyl 4-oxo-4H-pyr-
an-2,5-dicarboxylate (diethyl isochelidonate), is much less known.
Furthermore, none of the isomeric 4-pyrone dicarboxylic acids I–III
has been recorded in the literature (Fig. 1). Diethyl isochelidonate
was mentioned for the ﬁrst time in 2012 in the patent literature,6
as a novel intermediate for synthesizing an anti-inﬂuenza drug
exhibiting cap-dependent endonuclease inhibitory activity.
c-Pyrone derivatives bearing electron-withdrawing carbonyl-
containing substituents at the 2- and 5-positions have, surpris-
ingly, been poorly investigated, probably due to the limited num-
ber of methods available for their preparation.6,7 At the same
time, these compounds are an important class of c-pyrones which
can serve as the starting materials for the syntheses of a broad
range of heterocyclic systems due to the presence of ﬁveelectrophilic centers in their molecules (the C-2, C-4 and C-6 atoms
of the pyrone system, and the carbonyl carbons of the 2-COR and 5-
COR0 groups). The diverse range of properties of these compounds
is due to the fact that, being highly reactive geminally activated
push–pull alkenes with a good leaving group at the a- and a0-car-
bon atoms, whose role is played by the enolate anion, they acquire
the ability to undergo additional transformations related to c-pyr-
one ring-opening and heterocyclizations.
The present Letter describes an improved synthesis of diethyl
isochelidonate (1), which consists of the Claisen condensation of
ethyl 2-(dimethylamino)methylene-3-oxobutanoate with diethyl
oxalate in the presence of sodium hydride. Moreover, the synthesis.
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derivatives, including N-phenylisochelidamic acid, is presented.
Although the chemistry of 4-pyrones and 4-pyridones has been
well documented,8 isochelidonic and isochelidamic acids are hith-
erto unreported.
Within the framework of a research program on the synthetic
opportunities offered by the c-pyrone system in the preparation
of organic molecules having potential interest in biomedicinal
chemistry and materials science,9 we had a requirement for large
quantities of diethyl 4-oxo-4H-pyran-2,5-dicarboxylate (1). To
the best of our knowledge, there has only been one report on the
preparation of diester 1 via the reaction of ethyl 2-(dimethyl-
amino)methylene-3-oxobutanoate, prepared from ethyl acetoace-
tate and dimethylformamide dimethyl acetal,10 with ethyl oxalyl
chloride in the presence of hexamethyldisilazane in THF at
78 C.6 However, on repeating this procedure, we were unable
to obtain 1 in a reasonable yield. Instead, we found that the Claisen
condensation of ethyl 2-(dimethylamino)methylene-3-oxobutano-
ate with diethyl oxalate in the presence of sodium hydride in THF
at reﬂux for 5 h was the method of choice for the preparation of
isochelidonic ester 1. After cooling, the intermediate sodium salt
was ﬁltered, washed with THF (yield 64%), dissolved in water,
and quenched with concentrated HCl to give diester 1 in 83% yield
(overall yield 53%). Note that 1 could be prepared without isolation
of the sodium salt, however, a higher yield and easier puriﬁcation
of compound 1 were possible if the reaction was performed in a
two-step approach. Unlike the previously reported method,6 this
reaction did not require a low temperature or any chromatographic
puriﬁcation of the ﬁnal product, and thereby greatly facilitated the
preparation of the target diester 111 (Scheme 1).
As mentioned above, c-pyrone-2,5-dicarboxylates belong to a
poorly explored class of polycarbonyl compounds, the chemical
properties of which have not been investigated. In connection with
this, we examined the reactivity of diethyl 4-oxo-4H-pyran-2,5-
dicarboxylate (1) in order to obtain potentially biologically interest-
ing derivatives. We found that if the hydrolysis of diester 1was car-
ried out under milder conditions (conc. HCl, 20 C, 3 days), the
reaction could be stopped at the diacid 2 (yield 70%),12 whereas re-
ﬂux of 1 in dilute HCl (1:1) for 7 h gave comanic acid (3) in 47%
yield, which could also be obtained by decarboxylation of isocheli-
donic acid (2) under the same conditions (43% yield). These reac-
tions represent an alternative route to synthesize comanic acid
(3). Our approach makes it possible to obtain this compound from
acetoacetic ester in three steps (overall yield 25%), whereas the
method described in the literature13 for the synthesis of comanicO
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Scheme 1. Synthesis of compounds 1–3.acid (3) consists of ﬁve steps and starts from acetone and diethyl
oxalate via an acetonedioxalic ester (overall yield 33%).
There is no signiﬁcant difference in the chemical reactivity of
the 2- and 5-carbethoxy groups, and all our attempts to obtain
the monoester starting from diester 1 were unsuccessful. Thus,
an alternative method for the preparation of 5-carbethoxy-4-pyr-
one-2-carboxylic acid (4) was developed. We envisaged that the
reaction of 1 with piperidine would produce the corresponding
enaminone 5 with one deactivated carbethoxy group, the slow
reaction of which with water could be connected with the presence
of the electron-donating piperidine moiety. The second carbethoxy
group of the compound 5 will be activated toward nucleophilic at-
tack by the adjacent carbonyl group. In fact, we found that diethyl
isochelidonate (1) reacted readily with piperidine in ethanol at 0 C
for two hours and then at 20 C over two days to produce com-
pound 5 in 59% yield. This reaction involved attack of the NH group
at C-6 of 1 with concomitant opening of the pyrone ring to give 5,
which is a reactive polyfunctionalized intermediate with an intra-
molecular hydrogen bond. The 1H NMR spectrum of 5 displayed
broad signals for the piperidine function as a result of its only
slightly hindered rotation and there was no evidence of two geo-
metric isomers.10 Treatment of amino-enone 5 with dilute HCl
led to the starting pyrone 1, however, in line with our expectations,
basic hydrolysis of compound 5 at 0 C for 15 min followed by
acidiﬁcation successfully removed only one ethoxy group to give
monoethyl isochelidonate (4) in 72% yield14 (Scheme 2).
The structures of pyrones 2 and 4 were established from their
elemental analyses and spectral (1H, 13C NMR, and IR) data. In their
1H NMR spectra, protons H-3 and H-6 appeared as singlets at d
6.94–7.09 and d 8.86–9.00, respectively, in the 13C NMR spectra,
the pyrone carbonyls appeared at d 174.5 for monoester 4 and d
177.5 for diacid 2 (it is well-known15 that intramolecular hydrogen
bonding causes substantial downﬁeld shifts).
Thus, c-pyrone 1, due to activation of the conjugated system by
two electron-withdrawing carbethoxy groups, is a highly electro-
philic substrate, which is able to react with O- and N-nucleophiles,
with or without affecting the pyrone ring. During the preparation of
the isochelidamic acid derivatives, it was also found that treatment
of 1 with aniline at 0 C for 30 min gave amino-enone 6 as a 42:58
mixture of E- and Z-isomers in 81% yield. It is clear that the diester 1
reacts with aniline exclusively at its 6-position and in a 1,4-manner.
The main information for the characterization of this mixture was
obtained from the 1H NMR spectrum in CDCl3, which showed two1
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11.37 (d, J = 14.2 Hz, NH), 8.79 (d, J = 14.2 Hz, @CHN), 7.34 (s, @CH)
and at d 14.55 (s, OH), 12.53 (d, J = 13.5 Hz, NH), 8.63 (d, J = 13.5 Hz,
@CHN), 7.61 (s, @CH) were assigned tentatively to isomers Z-6 and
E-6, respectively. These data indicate that both labile protons are in-
volved in the formation of strong intramolecular hydrogen bonds,
thus conﬁrming the structure of 6.
In comparison to the reaction with piperidine, the use of
methanesulfonic acid in dichloromethane at room temperature
for three hours transformed amino-enone 6 irreversibly into
diethyl N-phenylisochelidamate (7) in 72% yield.16 Basic hydrolysis
of 7 proceeded in the expected manner to give N-phenylisochelida-
mic acid (8) (yield 88%),17 which may be of interest as a biologi-
cally valuable compound.6 Despite their rather simple structures,
neither compound 7 nor its parent acid 8 has been prepared previ-
ously; from this series of compounds only 5-carbethoxy-4-oxo-1,4-
dihydropyridine-2-carboxylic acid was known.18 Treatment of
amino-enone 6with a catalytic amount of concentrated HCl in eth-
anol at room temperature for 12 h gave a mixture of compounds 9
and 7 in the ratio of 1:3 (yield 48%) (Scheme 3).
In summary, we have developed an improved synthesis of bio-
logically potent diethyl 4-oxo-4H-pyran-2,5-dicarboxylate, which
involves the condensation of ethyl 2-(dimethylamino)methylene-
3-oxobutanoate with diethyl oxalate in the presence of sodium hy-
dride. Compared with the previously reported procedure, our
method shows several advantages, the main of which are simplic-
ity, efﬁciency, and the ready availability of the starting materials.
From this diester, for the ﬁrst time, isochelidonic acid and its deriv-
atives have been obtained in good yields. Taking into account the
ability to transform an ester group into other functional groups,
the 4-pyrone-2,5-dicarboxylate core is a valuable building block
for the construction of a wide range of 4-pyrone derivatives.
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